S-1/A: Concentra Group Holdings Parent Files for IPO, Aiming to Repay Debt

Concentra Group Holdings Parent, a subsidiary of Select Medical Corporation, has filed an S-1/A form with the SEC for its initial public offering, planning to use the proceeds to repay debt owed to Select Medical.

Summary

• Concentra Group Holdings Parent, Inc., has filed an amended registration statement (Form S-1/A) with the SEC for its initial public offering.
• The company intends to offer 22,500,000 shares of common stock, with an estimated IPO price between $23.00 and $26.00 per share.
• The primary purpose of the IPO is to repay debt owed to Select Medical Corporation (SMC), including $470.0 million of an intercompany note and $43.6 million of a promissory note issued as a dividend.
• The company will not use any of the net proceeds from this offering towards business operations and development.
• Select Medical will maintain at least 80.09% ownership of Concentra's common stock after the offering, making Concentra a controlled company under NYSE rules.
• The underwriters have a 30-day option to purchase up to an additional 3,375,000 shares.
• Select Medical intends to make a tax-free distribution to its stockholders of all its remaining equity interest in Concentra following the completion of this offering.
• The company has been approved to list its shares of common stock on the New York Stock Exchange (the NYSE) under the symbol CON.
• On July 11, 2024, Concentra Escrow Issuer Corporation completed a private offering of its 6.875% Senior Notes due 2032 in an aggregate principal amount of $650.0 million.
• In connection with this offering, CHSI intends to enter into credit facilities in an expected aggregate amount of $1,250.0 million, expected to be comprised of (a) a five-year revolving credit facility in the aggregate amount of $400.0 million and (b) a seven-year term loan facility in the aggregate principal amount of $850.0 million.
• Preliminary estimated results for the three months ended June 30, 2024 include revenue of $477.915 million and income from operations of $83.944 million.

Sentiment

Score: 7

Explanation: The document is largely neutral, providing factual information about the IPO and related transactions. The sentiment is slightly positive due to the mention of Select Medical's intention to distribute its remaining equity interest in Concentra to its stockholders in a tax-free distribution.

Positives

• The company has been approved to list its shares of common stock on the New York Stock Exchange (the NYSE) under the symbol CON.
• Select Medical received a private letter ruling from the IRS to the effect that the Distribution will be tax-free for U.S. federal income tax purposes to Select and its stockholders.
• Preliminary estimated results for the three months ended June 30, 2024 include revenue of $477.915 million and income from operations of $83.944 million.

Negatives

• The company will not use any of the net proceeds from this offering towards business operations and development.
• Select Medical will retain significant control, owning at least 80.09% of Concentra's common stock post-IPO.
• The company is using the IPO proceeds to repay debt to its parent company, Select Medical Corporation.

Risks

• Investing in shares of our common stock involves risks. See Risk Factors beginning on page 25 to read about factors you should consider before purchasing shares of our common stock.
• Select has agreed not to effect the Distribution for a period of 180 days after the date of this prospectus without the prior written consent of each of J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC.
• The conditions to the Distribution, including those discussed in The Separation and Distribution Transactions The Distribution, may not be satisfied, Select may decide not to consummate the Distribution even if the conditions are satisfied or Select may decide to waive one or more of the conditions and consummate the Distribution even if some or all of the conditions are not satisfied.

Future Outlook

Select Medical intends to make a tax-free distribution to its stockholders of all its remaining equity interest in Concentra following the completion of this offering.

Industry Context

The document positions Concentra as the largest provider of occupational health services in the United States, highlighting its national presence and partnerships with major employers. It also discusses industry trends such as the aging workforce, labor shortages, and increasing healthcare costs, suggesting that Concentra is well-positioned to address these challenges.

Comparison to Industry Standards

• The document does not provide a direct comparison to industry standards.
• However, it does mention that Concentra partners with approximately 200,000 employers, including 100% of Fortune 100 companies and approximately 95% of the Fortune 500, as of December 31, 2023.
• This suggests that Concentra has a strong market position and is a preferred provider for many large companies.

Related Party Transactions

• The primary purpose of the IPO is to repay debt owed to Select Medical Corporation (SMC), including $470.0 million of an intercompany note and $43.6 million of a promissory note issued as a dividend.
• Select Medical will maintain at least 80.09% ownership of Concentra's common stock after the offering, making Concentra a controlled company under NYSE rules.
• Select Medical intends to make a tax-free distribution to its stockholders of all its remaining equity interest in Concentra following the completion of this offering.

Stakeholder Impact

• Shareholders of Select Medical will receive shares of Concentra in a tax-free distribution.
• Employees of Concentra will transition to a standalone public company.
• Customers and partners of Concentra can expect continued service and potential for new offerings.

Next Steps

• The company will proceed with the initial public offering, subject to market conditions and regulatory approvals.
• Select Medical will determine the timing and conditions for the distribution of its remaining equity interest in Concentra.

Key Dates

Keywords

IPO, Concentra, Select Medical, Debt repayment, Initial public offering, Occupational health, SEC filing